Advertisement

Journal of Inherited Metabolic Disease

, Volume 31, Supplement 2, pp 209–211 | Cite as

Sensory-motor polyneuropathy occurring in variant maple syrup urine disease

  • S. Harty
  • M. D. King
  • B. McCoy
  • D. Costigan
  • E. P. Treacy
Short Report
  • 245 Downloads

Summary

Maple syrup urine disease (MSUD; OMIM 248600) results from an inherited deficiency of the branched-chain ketoacid dehydrogenase (BCKD) complex. Approximately 20% of patients with BCKD deficiency are non-classic variants of MSUD with differing clinical severity. Outcomes for this cohort are generally favourable; episodes of metabolic decompensation do not appear to correlate with adverse events if acute management is promptly provided. A case of predominantly axonal sensory-motor neuropathy following metabolic decompensation which persisted for a number of months is presented in an adolescent girl with variant (intermediate type) MSUD. EMG and nerve conduction studies suggested a pre-existent asymptomatic chronic neuropathy, exacerbated by the acute decompensation. Peak leucine concentration at decompensation was 1083 μmol/L. The patient had laboratory signs of secondary mitochondrial respiratory chain dysfunction at presentation. She had been on a moderate dose of thiamine prior to decompensation; thiamine and pyridoxine blood concentrations were normal. This, to our knowledge, is the first report of a neuropathy presenting in a patient with a decompensation of variant MSUD. We propose that this presentation resembles the intermittent neuropathy observed in pyruvate dehydrogenase deficiency and may reflect secondary inhibition of pyruvate dehydrogenase activity by MSUD metabolites.

Keywords

Nerve Conduction Study Maple Syrup Urine Disease Metabolic Decompensation Leucine Concentration Pyruvate Dehydrogenase Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Abbreviations

BCAA

branched-chain amino acid

BCKD

branched-chain ketoacid dehydrogenase

MSUD

maple syrup urine disease

References

  1. Buse MG, Biggers JF, Friderici KH, Buse JF (1972) Oxidation of branched chain amino acids by isolated hearts and diaphragms of the rat. The effects of fatty acids, glucose, and pyruvate respiration. J Biol Chem 247(24): 8085–8096.PubMedGoogle Scholar
  2. Chuang DT, Shih VE (2001) Maple syrup urine disease (branched-chain ketoaciduria): In: Scriver CR, Beaudet A, Valle D, eds: Childs B, Kinzler KW, Vogelstein B, assoc eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn, 2001. New York: McGraw-Hill, 1971–2007.Google Scholar
  3. Debray FG, Lambert M, Vanasse M, et al (2006). Intermittent peripheral weakness as the presenting feature of pyruvate dehydrogenase deficiency. Eur J Pediatr 165(7): 462–466. doi:10.1007/s00431-006-0104-5.PubMedCrossRefGoogle Scholar
  4. Kleopa KA, Raizen DM, Friedrich CA, Brown MJ, Bird SJ (2001). Acute axonal neuropathy in maple syrup urine disease. Muscle Nerve 24: 284–287. doi:10.1002/1097-4598(200102)24:2<284::AID-MUS140>3.0.CO;2-U.PubMedCrossRefGoogle Scholar
  5. Muller K, Kahn T, Wendel U (1993). Is demyelination a feature of maple syrup urine disease? Pediatr Neurol 9: 375–382. doi:10.1016/0887-8994(93)90106-M.PubMedCrossRefGoogle Scholar
  6. Ribeiro CA, Sgaravatti AM, Rosa RB, et al (2008). Inhibition of brain energy metabolism by the branched –chain amino acids accumulating in maple syrup urine disease. Neurochem Res 33(1): 114–124. doi:10.1007/s11064-007-9423-9.PubMedCrossRefGoogle Scholar
  7. Sgaravatti AM, Rosa RB, Schuck PF, Ribeiro CA, et al (2003). Inhibition of brain energy metabolism by the alpha-keto acids accumulating in maple syrup urine disease. Biochim Biophys Acta 1639(3): 232–238.PubMedGoogle Scholar
  8. Simon E, Flaschker P, Schadewaldt P, Langenbeck U, Wendel U (2006). Variant maple syrup urine disease (MSUD)–The entire spectrum. J Inherit Metab Dis 29: 716–724. doi:10.1007/s10545-006-0276-1.PubMedCrossRefGoogle Scholar
  9. Wendel U, Langenbeck U, Seakins JW (1989). Interrelation between the metabolism of l-isoleucine and l-allo- isoleucine in patients with maple syrup urine disease. Pediatr Res 25: 11–14. doi:10.1203/00006450-198901000-00003.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  • S. Harty
    • 1
  • M. D. King
    • 2
  • B. McCoy
    • 2
  • D. Costigan
    • 2
  • E. P. Treacy
    • 1
  1. 1.National Centre for Inherited Metabolic DisordersChildren’s University HospitalDublin 1Ireland
  2. 2.Department of NeurologyChildren’s University HospitalDublinIreland

Personalised recommendations